Showing results (211-220 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancerAlexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.Journal for Immunotherapy of Cancer|April 9, 2022
New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosisShuichi Shinohara, Yusuke Takahashi, Hiroyasu Komuro, et al.Journal for Immunotherapy of Cancer|March 31, 2022
Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapyMegan L Baker, Yu Yamamoto, Mark A Perazella, et al.Journal for Immunotherapy of Cancer|October 20, 2021
MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomasQiang-Wei Wang, Li-Hua Sun, Ying Zhang, et al.Journal for Immunotherapy of Cancer|October 20, 2021
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forwardMaria Rain Jennings, David Munn, John BlazeckJournal for Immunotherapy of Cancer|February 25, 2022
Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancerIngunn M Stromnes, Ayaka Hulbert, Meagan R Rollins, et al.Journal for Immunotherapy of Cancer|February 25, 2022
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trialScott S Tykodi, Lucio N Gordan, Robert S Alter, et al.Journal for Immunotherapy of Cancer|March 9, 2022
Generalizable design parameters for soluble T cell receptor-based T cell engagersKaren J Froning, Arlene Sereno, Flora Huang, et al.Journal for Immunotherapy of Cancer|February 26, 2022
Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survivalZiena Abdulrahman, Saskia J Santegoets, Gregor Sturm, et al.Journal for Immunotherapy of Cancer|March 10, 2022
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin STom J Harryvan, Marten Visser, Linda de Bruin, et al.Pageof 424